Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2)
NCT04863872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 259
Last updated 2025-05-06
Summary
Severe hypoglycemia is the most feared complication of medications used to lower blood glucose levels in patients with diabetes. Severe hypoglycemia, defined as plasma glucose low enough to require assistance, has been linked to poor health-related quality of life, emotional and interpersonal challenges, car accidents, serious falls, cardiovascular events, dementia, and death. Older adults with type 2 diabetes are particularly vulnerable to the complications of severe hypoglycemia. Each year, approximately 11% of patients with type 2 diabetes self-report severe hypoglycemia episodes. An estimated 14% of emergency hospitalizations of older Americans for adverse drug events implicate insulin and 11% implicate oral hypoglycemic agents. One in four diabetes-related hospital admissions is for hypoglycemia.
This study will compare two ways to reduce severe hypoglycemia in people with type 2 diabetes. The two methods to be compared are:
1. Proactive care management. This will be a nurse outreach call which is similar to the usual care that people with type 2 diabetes get to reduce their risk of severe hypoglycemia, but given in advance rather than in response to a recent severe hypoglycemia event.
2. The same proactive care management (nurse outreach call) plus enrollment in MyHC-T2D, a health education program aimed at improving awareness of hypoglycemia and preventing severe hypoglycemia. This program has been shown to reduce severe hypoglycemia in people with type 1 diabetes but has not been tested in persons with type 2.
Our hypothesis is that proactive care management plus MyHC-T2D will be more effective than proactive care management alone at preventing self-reported severe hypoglycemia in adults with type 2 diabetes at high risk for severe hypoglycemia. The primary outcome will be measured using surveys at the beginning of the study and 14-months later.
Conditions
- Severe Hypoglycemia
Interventions
- OTHER
-
Proactive Care Management
Participants will receive one telephone nurse outreach call with follow up by the nurse or their primary care provider as clinically indicated.
- BEHAVIORAL
-
MyHC-T2D education program
Participants will be enrolled in a structured education program designed to improve hypoglycemia awareness and reduce severe hypoglycemia. The structured program will include 2 online group education sessions, 2 nurse follow up calls and use of glucose and hypoglycemia diaries, delivered over approximately 3 months.
Sponsors & Collaborators
-
Patient-Centered Outcomes Research Institute
collaborator OTHER -
Kaiser Permanente
lead OTHER
Principal Investigators
-
James Ralston, MD, MPH · Kaiser Permanente
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-26
- Primary Completion
- 2024-04-24
- Completion
- 2024-06-21
Countries
- United States
Study Locations
More Related Trials
-
Hypoglycemia: Physician and Patient Perspectives
NCT01176656 ·Status: COMPLETED
-
Hypoglycaemia Awareness Restoration Programme
NCT02940873 ·Status: COMPLETED ·Phase: NA
-
Preventing Hypoglycemia
NCT01923688 ·Status: COMPLETED ·Phase: NA
-
Hypoglycemia in Hospitalized Patients
NCT02228642 ·Status: COMPLETED
-
Primary Care Clinicians' Responses to a Hypoglycemia Risk Calculator for Diabetes Mellitus in Ambulatory Care
NCT04177147 ·Status: COMPLETED ·Phase: NA
-
Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients
NCT03510078 ·Status: COMPLETED ·Phase: NA
-
Identification of Inpatients at Risk for Poor Glycemic Control
NCT01043042 ·Status: COMPLETED
-
Naltrexone and Hypoglycemia in Type 1 Diabetes
NCT01053078 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hypoglycemia (Low Blood Sugar) and the Heart
NCT01980914 ·Status: COMPLETED ·Phase: NA
-
Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
NCT01283126 ·Status: COMPLETED ·Phase: NA
-
The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity
NCT00160056 ·Status: COMPLETED ·Phase: NA
-
Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
NCT01462227 ·Status: COMPLETED ·Phase: NA
-
Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy
NCT02155374 ·Status: COMPLETED ·Phase: PHASE4
-
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
NCT00812487 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hypoglycemia and the Mineralocorticoid Receptor
NCT01394627 ·Status: COMPLETED ·Phase: NA
-
Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia
NCT01865760 ·Status: COMPLETED ·Phase: NA
-
Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital
NCT02868606 ·Status: COMPLETED
-
Prevention of Severe Hypoglycaemia With Hypo-Safe Hypoglycaemia Alarm Device
NCT01178476 ·Status: WITHDRAWN ·Phase: NA
-
Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes
NCT04876079 ·Status: COMPLETED ·Phase: NA
-
Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)
NCT01033773 ·Status: COMPLETED ·Phase: NA
-
A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes
NCT03102801 ·Status: COMPLETED ·Phase: NA
-
Hypoglycaemia in People With Type 2 Diabetes in Primary Care
NCT02666521 ·Status: COMPLETED
-
Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes
NCT02866435 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin
NCT02486341 ·Status: COMPLETED ·Phase: NA
-
Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
NCT01841359 ·Status: COMPLETED ·Phase: PHASE4